Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR
Frank Berthold, Andreas Faldum, Angela Ernst, Joachim Boos, Dagmar Dilloo, Angelika Eggert, Matthias Fischer, Michael C. Frühwald, G. Henze, Thomas Klingebiel, Christian P. Kratz, Bernhard Kremens, Barbara Krug, Ivo Leuschner, Matthias Schmidt, René Schmidt, Roswitha Schumacher‐Kuckelkorn, Dietrich von Schweinitz, F. Schilling, Jessica Theißen, Ruth Volland, Barbara Hero, Thorsten Simon
Topics & Concepts
MedicineTopotecanInduction chemotherapyEtoposideChemotherapySurgeryClinical endpointInternal medicineCyclophosphamideOncologyRandomized controlled trialNeuroblastoma Research and TreatmentsCancer therapeutics and mechanismsCancer, Hypoxia, and Metabolism